Progyny (PGNY) Cost of Revenue (2018 - 2026)

Progyny (PGNY) has 9 years of Cost of Revenue data on file, last reported at $245.4 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $245.4 million, down 1.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $535.3 million (down 27.23% YoY), and the FY2025 annual result was $984.2 million, up 1439.03% from the prior year.
• Cost of Revenue grew to $245.4 million in Q1 2026 per PGNY's latest filing, from $18.0 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $253.9 million in Q2 2025 and troughed at $13.0 million in Q4 2022.
• A 5-year average of $130.1 million and a median of $151.1 million in 2022 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue soared 3488.74% in 2022, then tumbled 92.46% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $13.0 million in 2022, then advanced by 14.88% to $14.9 million in 2023, then surged by 1476.01% to $235.0 million in 2024, then slumped by 92.35% to $18.0 million in 2025, then soared by 1264.5% to $245.4 million in 2026.
• Business Quant data shows PGNY's Cost of Revenue at $245.4 million in Q1 2026, $18.0 million in Q4 2025, and $17.9 million in Q3 2025.